Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4892]

European Commission approves reduced dosing frequency of teclistamab for multiple myeloma

European Commission approves reduced dosing frequency of teclistamab for multiple myeloma

A computational genetic model will make it possible to predict increased genetic risk for breast cancer

A computational genetic model will make it possible to predict increased genetic risk for breast cancer

Replicating the internal environment of a lung cancer patient’s body

Replicating the internal environment of a lung cancer patient’s body

Study brings insight to kidney cancer with gene mutation

Study brings insight to kidney cancer with gene mutation

New technique illuminates how abnormal RNA splicing leads to disease

New technique illuminates how abnormal RNA splicing leads to disease

A medication used for heart conditions improves the efficacy of current treatments for melanoma in mouse models

A medication used for heart conditions improves the efficacy of current treatments for melanoma in mouse models

Inhibition of prmt5 by repurposing market drugs - a fresh therapeutic pathway for cancer treatment

Inhibition of prmt5 by repurposing market drugs - a fresh therapeutic pathway for cancer treatment

$FDA grants accelerated approval to talquetamab-tgvs for relapsed or refractory multiple myeloma$

FDA grants accelerated approval to talquetamab-tgvs for relapsed or refractory multiple myeloma

Does access to assisted suicide affect trends of conventional suicide among patients with cancer?

Does access to assisted suicide affect trends of conventional suicide among patients with cancer?

CDK9 Inhibitors: A promising combination partner in treating haematological malignancies

CDK9 Inhibitors: A promising combination partner in treating haematological malignancies

More from ecancer